Skip to Main Content

Paper Details

APOL1 Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study.
Am J Nephrol
0
2022
APOL1, APOL1 Risk Variants, APOL1 high-risk variants, C-reactive protein, CKD, ESKD, Serum Albumin, Stroke, albumin, apolipoprotein L1, apolipoprotein L1 (APOL1) nephropathy risk variants, chronic kidney disease, diabetes, end-stage kidney disease, hypertension, nephropathy, participants, people, sALB, serum albumin, systemic inflammation, white blood cell
Author NameAffiliation
Hemant K TiwariUniversity of Alabama at Birmingham
Hemant K TiwariUniversity of Alabama at Birmingham
Bertha HidalgoUniversity of Alabama at Birmingham
Nita A LimdiUniversity of Alabama at Birmingham
Leslie A LangeUniversity of Colorado Denver - Anschutz Medical Campus
Jeffrey B KoppNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Marguerite R IrvinUniversity of Alabama at Birmingham
  • 1 - 7

Datasets

Release 1.2